CD27 Ligand/TNFSF7/CD70 Antibody (301731) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB2738JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # 301731
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human CD27 Ligand/TNFSF7
Gln45-Pro193
Accession # AAA36175
Gln45-Pro193
Accession # AAA36175
Specificity
Detects human CD27 Ligand/TNFSF7 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for CD27 Ligand/TNFSF7/CD70 Antibody (301731) [Janelia Fluor® 669]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CD27 Ligand/TNFSF7
Alternate Names
CD70, TNFSF7
Gene Symbol
CD70
Additional CD27 Ligand/TNFSF7 Products
Product Documents for CD27 Ligand/TNFSF7/CD70 Antibody (301731) [Janelia Fluor® 669]
Product Specific Notices for CD27 Ligand/TNFSF7/CD70 Antibody (301731) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...